ADVFN ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Acadia Pharmaceuticals Inc

Acadia Pharmaceuticals Inc (ACAD)

21,72
0,29
(1,35%)
Alla chiusura: 04 Giugno 10:00PM
21,72
0,00
( 0,00% )
Dopo le ore di negoziazione: 10:30PM

Acadia Pharmaceuticals Inc (ACAD) Operazioni degli insider

-
Filtra per:
Data Nome del titolare Azioni transazionate Intervallo di valore ($) Tipo di transazione Intervallo di prezzo ($) Azioni a fine dichiarazione % di variazione
2026-05-29Ms. Laura A. BregeIndependent Director8,11k0,00Derivative Exercise and Retained Stock-23,20k53,71%
2026-05-29Mr. James M. DalyIndependent Director8,11k0,00Derivative Exercise and Retained Stock-12,15k200,62%
2026-05-29Dr. Edmund P. HarriganIndependent Director8,11k0,00Derivative Exercise and Retained Stock-43,15k23,14%
2026-05-29Mr. Jonathan M. PooleIndependent Director2,01k0,00Derivative Exercise and Retained Stock-2,01k-
2026-05-29Dr. Elizabeth A. GarofaloIndependent Director8,11k0,00Derivative Exercise and Retained Stock-33,49k31,94%
2026-05-29Dr. Adora NduIndependent Director8,11k0,00Derivative Exercise and Retained Stock-32,91k32,69%
2026-05-01Mr. Mark C. SchneyerExec. VP & CFO3,31k0,00Derivative Exercise and Retained Stock-66,15k5,27%
2026-05-01Mr. Mark C. SchneyerExec. VP & CFO-3,51k76,40kDerivative Exercise and Sale21,7966,15k-
2026-05-01Mr. James K. KiharaSVP of Finance1,26k0,00Derivative Exercise and Retained Stock-29,13k4,54%
2026-05-01Mr. James K. KiharaSVP of Finance-1,33k29,02kDerivative Exercise and Sale21,7929,13k-
2026-04-05Mr. Mark C. SchneyerExec. VP & CFO2,57k0,00Derivative Exercise and Retained Stock-62,84k4,26%
2026-04-05Mr. Mark C. SchneyerExec. VP & CFO-2,71k60,14kDerivative Exercise and Sale22,2062,84k-
2026-04-05Mr. James K. KiharaSVP of Finance980,000,00Derivative Exercise and Retained Stock-27,87k3,65%
2026-04-05Mr. James K. KiharaSVP of Finance-1,03k22,87kDerivative Exercise and Sale22,2027,87k-
2026-03-24Mr. James K. KiharaSVP of Finance1,83k0,00Derivative Exercise and Retained Stock-26,89k7,29%
2026-03-24Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary-3,84k82,53kDerivative Exercise and Sale21,4711,28k-
2026-03-24Mr. Mark C. SchneyerExec. VP & CFO-7,39k159,14kDerivative Exercise and Sale21,47 - 21,7260,27k-
2026-03-24Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary3,67k0,00Derivative Exercise and Retained Stock-11,28k48,25%
2026-03-24Mr. Mark C. SchneyerExec. VP & CFO6,93k0,00Derivative Exercise and Retained Stock-60,27k12,99%
2026-03-24Ms. Catherine E. Owen AdamsCEO & Director-11,64k249,93kDerivative Exercise and Sale21,4714,80k-
2026-03-24Dr. Elizabeth H. Z. ThompsonExec. VP and Head of Research & Development-3,44k73,75kDerivative Exercise and Sale21,473,28k-
2026-03-24Dr. Elizabeth H. Z. ThompsonExec. VP and Head of Research & Development3,28k0,00Derivative Exercise and Retained Stock-3,28k-
2026-03-24Mr. James K. KiharaSVP of Finance-1,94k41,90kDerivative Exercise and Sale21,47 - 21,7326,89k-
2026-03-24Ms. Catherine E. Owen AdamsCEO & Director11,87k0,00Derivative Exercise and Retained Stock-14,80k404,36%
2026-02-06Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary5,99k0,00Derivative Exercise and Retained Stock-7,61k371,15%
2026-02-06Ms. Jennifer J. RhodesExec. VP, Chief Legal Officer & Secretary-6,95k162,49kDerivative Exercise and Sale23,387,61k-
2025-11-17Mr. Mark C. SchneyerExec. VP & CFO9,56k0,00Derivative Exercise and Retained Stock-53,34k21,85%
2025-11-17Mr. Mark C. SchneyerExec. VP & CFO-10,26k243,11kDerivative Exercise and Sale23,6953,34k-
2025-11-17Mr. James K. KiharaSVP of Finance3,85k0,00Derivative Exercise and Retained Stock-25,06k18,14%
2025-11-17Mr. James K. KiharaSVP of Finance-4,08k96,75kDerivative Exercise and Sale23,6925,06k-
2025-11-10Mr. James M. DalyIndependent Director-30,00k670,98kVendita22,374,04k-88,13%
2025-09-15Mr. Mark C. SchneyerExec. VP & CFO-3,50k82,73kAutomatic Disposition23,6543,45k-7,45%
2025-09-02Dr. Elizabeth A. GarofaloIndependent Director-1,60k41,56kVendita25,9825,38k-5,93%
2025-08-18Mr. Mark C. SchneyerExec. VP & CFO-22,00k554,02kAutomatic Disposition25,1840,13k-35,41%
2025-06-04Ms. Laura A. BregeIndependent Director-14,45k314,63kVendita21,7815,10k-48,90%